The European Commission has launched a Manifesto to maximise the accessibility of research results in the fight against COVID-19 and Asphalion has signed it to reinforce its commitment to bring solutions and alternatives to fight this pandemic situation.

Since the beginning of the COVID-19 crisis, Asphalion has always offered all its expertise in Regulatory Affairs by:

  • Participating in clinical trials related to potential COVID-19 treatments.
  • Providing advice and guidance at clinical, technical and procedural levels to facilitate the availability and authorisation of medical devices and personal protection equipment as soon as possible.
  • Participating in research projects in the extraordinary COVID-19 call done by the EU through Horizon 2020.

We would like to keep supporting in whatever is needed at this time so do not hesitate to contact us if you need help: covid19@asphalion.com

Subscribirse al Directorio
Escribir un Artículo

Últimas Noticias

Uso de RNA móviles para mejorar la asim...

El gen AtCDF3 promueve una mayor producción de az...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Destacadas

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

En nuestro post hablamos sobre este interesante tipo de célula del si...

La combinación de ayuno y quimioterapia...

by CNIO - Centro Nacional de Investigaciones Oncológicas

Un nuevo estudio muestra que el efecto positivo de combinar ayuno y qu...

Diapositiva de Fotos